Latest News

Healthcare systems are facing rising operating pressure, thinner margins, and a harder question about how to manage liquidity across the balance sheet as capital needs become more uncertain. Liquidity

Reconnaissance Energy Africa earlier this week announced the successful production of the first onshore hydrocarbons in Namibia during testing at its Kavango well, marking an important milestone for b

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Verra To Contact Him Directly To Discuss Their Options If you purchased or acquired s

According to Visible Alpha consensus, Amazon's total revenue for North America of $113.8 billion expected for Q2 edged upward since the February 2026 release. The International operating profit margin

With the quick rise of Moonshot AI's Kimi K3, the topic of distillation has become a hot-button issue among techies and lawmakers. Moonshot's offering is one of many coming out of China, where develop

Shipping and logistics companies are tapping into the growing healthcare market as cold chain and temperature-controlled facilities become more crucial. Those companies are investing millions of dolla

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nano-X To Contact Him Directly To Discuss Their Options If you purchased or acquired

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Badger Meter To Contact Him Directly To Discuss Their Options If you purchased or acq

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Photronics To Contact Him Directly To Discuss Their Options If you purchased or acqui

Verizon is a buy for long-term income investors, driven by aggressive leadership, improving execution, and a forward P/E under 9x. VZ delivered strong Q2 results: EPS up 6.5%, record EBITDA margin of

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Peabody Energy To Contact Him Directly To Discuss Their Options If you purchased or a

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Via Transportation To Contact Him Directly To Discuss Their Options If you purchased

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lucid Group To Contact Him Directly To Discuss Their Options If you purchased or acqu

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Intuit To Contact Him Directly To Discuss Their Options If you purchased or acquired

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In PicS To Contact Him Directly To Discuss Their Options If you purchased or acquired Pi

Medpace Holdings demonstrates strong Q2 2026 net new business awards, with a 1.13x net book-to-bill and $3.0B backlog. Oncology bookings are robust, while cardiometabolic awards have declined; managem

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their Options If you purchased or acquired s

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Megan To Contact Him Directly To Discuss Their Options If you purchased or acquired s

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their Options If you purchased or acquired

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ADMA Biologics To Contact Him Directly To Discuss Their Options If you purchased or a